Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis. 2015

Sidsel Støy, and Anders Dige, and Thomas Damgaard Sandahl, and Tea Lund Laursen, and Christian Buus, and Marianne Hokland, and Hendrik Vilstrup
Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark; and sidsel.stoy@post.au.dk.

The dynamics and role of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and NKT cells in the life-threatening inflammatory disease alcoholic hepatitis is largely unknown. These cells directly kill infected and damaged cells through, e.g., degranulation and interferon-γ (IFNγ) production, but cause tissue damage if overactivated. They also assist tissue repair via IL-22 production. We, therefore, aimed to investigate the frequency, functionality, and activation state of such cells in alcoholic hepatitis. We analyzed blood samples from 24 severe alcoholic hepatitis patients followed for 30 days after diagnosis. Ten healthy abstinent volunteers and 10 stable abstinent alcoholic cirrhosis patients were controls. Using flow cytometry we assessed cell frequencies, NK cell degranulation capacity following K562 cell stimulation, activation by natural killer group 2 D (NKG2D) expression, and IL-22 and IFNγ production. In alcoholic hepatitis we found a decreased frequency of CTLs compared with healthy controls (P < 0.001) and a similar trend for NK cells (P = 0.089). The NK cell degranulation capacity was reduced by 25% compared with healthy controls (P = 0.02) and by 50% compared with cirrhosis patients (P = 0.04). Accordingly, the NKG2D receptor expression was markedly decreased on NK cells, CTLs, and NKT cells (P < 0.05, all). The frequencies of IL-22-producing CTLs and NK cells were doubled compared with healthy controls (P < 0.05, all) but not different from cirrhosis patients. This exploratory study for the first time showed impaired cellular cytotoxicity and activation in alcoholic hepatitis. This is unlikely to cause hepatocyte death but may contribute toward the severe immune incompetence. The results warrant detailed and mechanistic studies.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008231 Lymphopenia Reduction in the number of lymphocytes. Lymphocytopenia,Lymphocytopenias,Lymphopenias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females

Related Publications

Sidsel Støy, and Anders Dige, and Thomas Damgaard Sandahl, and Tea Lund Laursen, and Christian Buus, and Marianne Hokland, and Hendrik Vilstrup
May 2011, Virology journal,
Sidsel Støy, and Anders Dige, and Thomas Damgaard Sandahl, and Tea Lund Laursen, and Christian Buus, and Marianne Hokland, and Hendrik Vilstrup
June 1992, European journal of immunology,
Sidsel Støy, and Anders Dige, and Thomas Damgaard Sandahl, and Tea Lund Laursen, and Christian Buus, and Marianne Hokland, and Hendrik Vilstrup
October 1985, Cellular immunology,
Sidsel Støy, and Anders Dige, and Thomas Damgaard Sandahl, and Tea Lund Laursen, and Christian Buus, and Marianne Hokland, and Hendrik Vilstrup
September 1992, Pharmacological research,
Sidsel Støy, and Anders Dige, and Thomas Damgaard Sandahl, and Tea Lund Laursen, and Christian Buus, and Marianne Hokland, and Hendrik Vilstrup
January 1994, Immunology,
Sidsel Støy, and Anders Dige, and Thomas Damgaard Sandahl, and Tea Lund Laursen, and Christian Buus, and Marianne Hokland, and Hendrik Vilstrup
October 2003, Transplantation,
Sidsel Støy, and Anders Dige, and Thomas Damgaard Sandahl, and Tea Lund Laursen, and Christian Buus, and Marianne Hokland, and Hendrik Vilstrup
December 2015, Journal of acquired immune deficiency syndromes (1999),
Sidsel Støy, and Anders Dige, and Thomas Damgaard Sandahl, and Tea Lund Laursen, and Christian Buus, and Marianne Hokland, and Hendrik Vilstrup
October 1983, Journal of immunology (Baltimore, Md. : 1950),
Sidsel Støy, and Anders Dige, and Thomas Damgaard Sandahl, and Tea Lund Laursen, and Christian Buus, and Marianne Hokland, and Hendrik Vilstrup
September 2009, Chinese medical journal,
Sidsel Støy, and Anders Dige, and Thomas Damgaard Sandahl, and Tea Lund Laursen, and Christian Buus, and Marianne Hokland, and Hendrik Vilstrup
May 1992, European journal of immunology,
Copied contents to your clipboard!